NCT01757691View on ClinicalTrials.gov

Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Acute Demylelinating Optic Neuritis
Interventions
DRUG

Fingolimod 0.5mg/daily

DRUG

Placebo

Trial Locations (2)

28222

Novartis Investigative Site, Majadahonda

33713

Novartis Investigative Site, St. Petersburg

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY